Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Mammographic Breast Density Effect of Aspirin: a Companion Study to Alliance Study A011502

NCT03609021 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT03609021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03609021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Mammographic Breast Density Effect of Aspirin: a Companion Study to Alliance Study A011502
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Observational
Overall status
Terminated
Start date
February 26, 2019
Completion date
July 18, 2022
Enrollment
18 (actual)
Sites
515

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, estrogen receptor negative, progesterone receptor negative